CLINICAL_TRIALS
research
· 2025-11-17
Clinical Trial Update: Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors [Phase 4]
Summary
Phase 4 clinical trial evaluating light-assisted ex vivo treatment and antiviral strategies for recipients of lungs from HBV-infected donors; recruitment is ong…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Health Network, Toronto | Conditions: Hepatitis B Virus (HBV), Lung Transplant Recipient | Phase 4 | Status: RECRUITING